| CSP | carotid sinus pressure; cavum septi pellucidi; cell surface protein; cerebrospinal protein; Chartere... |
|---|---|
| MCP | maximum closure pressure; maximum contraction pattern; malanocortin receptor; melphalan, cyclophosph... |
| SCP | single-celled protein; standard care plan; sodium cellulose phosphate; soluble cytoplasmic protein; ... |
| TP | temperature and pressure; temperature probe; temporal peak; temporoparietal; tension pneumothorax; t... |
| TSP | testis-specific protein; thrombin-sensitive protein; thrombospondin; total serum protein; total susp... |
| status sternuens | A state of continual sneezing. (05 Mar 2000) |
|---|---|
| status thymicolymphaticus | Old term for a syndrome of supposed enlargement of the thymus and lymph nodes in infants and young children, formerly believed to be associated with unexplained sudden death; it was also erroneously believed that pressure of the thymus on the trachea might cause death during anaesthesia. Prominence of these structures is now considered normal in young children, including those who have died suddenly without preceding illnesses that might lead to atrophy of lymphoid tissue. See: sudden infant death syndrome. Synonym: status lymphaticus, status thymicus. (05 Mar 2000) |
| status thymicus | Old term for a syndrome of supposed enlargement of the thymus and lymph nodes in infants and young children, formerly believed to be associated with unexplained sudden death; it was also erroneously believed that pressure of the thymus on the trachea might cause death during anaesthesia. Prominence of these structures is now considered normal in young children, including those who have died suddenly without preceding illnesses that might lead to atrophy of lymphoid tissue. See: sudden infant death syndrome. Synonym: status lymphaticus, status thymicus. (05 Mar 2000) |
| status typhosus | Rarely used term for an erethistic or typhoidal state. Synonym: status nervosus. (05 Mar 2000) |
| status vertiginosus | A condition in which attacks of vertigo occur in rapid succession. Synonym: chronic vertigo. (05 Mar 2000) |
| nutritional status | State of the body in relation to the consumption and utilization of nutrients. (12 Dec 1998) |
| ind status | Status given an experimental drug after the FDA approves an application for testing it in people. (09 Oct 1997) |
| educational status | Educational attainment or level of education of individuals. (12 Dec 1998) |
| karnofsky performance status | A performance measure for rating the ability of a person to perform usual activities, evaluating a patient's progress after a therapeutic procedure, and determining a patient's suitability for therapy. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for dr. David a. Karnofsky, an american specialist in cancer chemotherapy. (12 Dec 1998) |
| acetoacetyl-acyl carrier protein synthase | <enzyme> E coli enzyme, that catalyses condensation of malonyl-acyl carrier protein plus acetyl-acyl carrier protein; not inhibited by cerulenin Registry number: EC 2.3.1.- Synonym: acetoacetyl-acp synthase (26 Jun 1999) |
| acid soluble spore protein | <molecular biology> A DNA binding protein in the spores of some bacteria, thought to stabilise the DNA in an A configuration, so protecting it from cleavage by enzymes or UV light. (18 Nov 1997) |
| acute-phase protein | <haematology> These plasma proteins (in addition to fibrinogen) increase 25% or more in response to inflammation and injury are under direct control of interleukin-6 (IL-6) (hepatocyte-stimulating factor). Other proteins which increase are ceruloplasmin, C3 and C4 which increase 50% or more; alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin and fibrinogen (the major determinant of viscosity 1 ) which increase two- to fourfold; C-reactive protein (CRP) and serum amyloid A which increase several hundred-fold. Despite long-held clinical opinion to the contrary, available data indicate that neither ESR nor measurement of specific acute-phase reactants are useful in excluding underlying infection or inflammation regardless of the pretest probability. These proteins are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. They can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumour markers. See also: amyloid, c-reactive protein, erythrocyte sedimentation rate, viscosity. (25 Jun 1999) |
| acyl-(acyl-carrier-protein)-phospholipid acyltransferase | <enzyme> Catalyses the formation of phosphatidylethanolamine from acyl-acyl carrier protein and 2-acyl-sn-glycero-3-phosphoethanolamine Registry number: EC 2.3.1.40 Synonym: 2-acyl-gpe acyltransferase, 2-acylglycerophosphoethanolamine acyltransferase (26 Jun 1999) |
| acyl-(acyl-carrier-protein)-UDP-N-acetylglucosamine acyltransferase | <enzyme> E coli enzyme involved in lipid a biosynthesis; uses beta-hydroxymyristoyl-acyl carrier protein to form udp-3-monoacyl-n-acetylglucosamine; amino acid sequence given in second source Registry number: EC 2.3.1.129 Synonym: udp-aguatransferase, lpxa protein, udp-n-acetylglucosamine-3-acyltransferase, udp-n-acetylglucosamine 3-o-acyltransferase, udp-3-o-(r-3-hydroxymyristoyl)glucosamine-n-acyltransferase, lpxd protein, fira gene product, fira protein (26 Jun 1999) |
| acyl carrier protein | <protein> A small (77 peptides long) protein which binds six other enzymes involved in fatty acid synthesis. It was first isolated in E. Coli bacteria. (09 Oct 1997) |